REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/04/2026
Back to search
Official data from USPTO
PHARMATHEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PHARMATHEN
ST13
US500000086855211Class
5, 35, 41, 42, 44
Filing
86855211
Registration
5174238
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/05/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 35, 41, 42, 44
Filing date
12/21/2015
Registration date
04/04/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2024
Last transaction
04/05/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Marousi, Attica, GR
Examiner
DOMBROW, COLLEEN M
Current location
Historical data usage
Holders and representatives
Holders
Pharmathen S.A.
Pharmathen S.A.
Representatives
Bradford C. Craig BLANK ROME LLP
Technical classification
Nice Classes
Class 5Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Generic pharmaceutical preparation for the treatment of gout; Generic pharmaceutical preparations acting on the central nervous system; Generic pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Generic pharmaceutical preparations for animal skincare; Generic pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Generic pharmaceutical preparations for ocular or intraocular surgery; Generic pharmaceutical preparations for the treatment of heart rhythm disorders; Generic pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Generic pharmaceutical preparations for the treatment of infectious diseases; Generic pharmaceutical preparations for treating allergic rhinitis and asthma; Generic pharmaceutical preparations for treating diabetes; Generic pharmaceutical preparations for treating skin disorders; Generic pharmaceutical preparations for use in chemotherapy; Generic pharmaceutical preparations for use in dermatology; Generic pharmaceutical preparations for use in urology; Generic pharmaceutical preparations for wounds; Generic pharmaceutical preparationsanticoagulants; Generic pharmaceutical preparationsantidepressants; Generic pharmaceutical preparationsappetite suppressants. Generic pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; Generic pharmaceutical preparationsa drug delivery system comprising polymerbased oral tablets for the continuous release of a wide variety of therapeutic agents; Preparations for destroying parasites; Preparations for destroying vermin; Sanitary preparations for medical use; Self adhesive dressings; Veterinary preparationspain relief medication
Class 35
Providing advertisingmarketing and promotional services for the generic pharmaceutical and medical industry. Providing advertisingmarketing and promotional services for the generic pharmaceuticals and medical products of others; Providing information on the topic of promoting patientphysician and employee satisfaction via a global computer network
Class 41
Education servicesmentoring in the field of generic pharmaceuticalsdiagnostic preparationsveterinary preparationsproprietary medicinestoiletries and cosmetics; Educational servicesproviding classesseminars and workshops in the fields of generic pharmaceuticalsdiagnostic preparationsveterinary preparationsproprietary medicinestoiletries and cosmetic industries; Providing continuing medical education courses
Class 42
Medical and scientific research services in the field of cancer treatment and diagnosis; Generic pharmaceutical drug development services; generic Pharmaceutical research services; Professional consulting services and advice about agricultural chemistry; Scientific consulting and research services relating to foods and dietary supplements; Technical consultancy in relation to research services relating to foods and dietary supplements; Scientific investigations for medical purposes in the field of generic pharmaceuticals; Scientific research in the field of generic pharmaceuticals; Scientific research and development in the field of generic pharmaceuticals
Class 44
Medical services; Providing health care information by telephone; Providing health care information by telephone and the Internet; Providing health information; Providing information about beauty; Providing medical informationconsultancy and advisory services in the field of generic pharmaceuticals; Veterinary services
Publications
History of USPTO decisions and trademark events.
31 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/19/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/19/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/22/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
09/22/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/22/2023
E815
TEAS SECTION 8 & 15 RECEIVED
03/22/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2017
PUBO
PUBLISHED FOR OPPOSITION
01/17/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/13/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/01/2016
ALIE
ASSIGNED TO LIE
11/10/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/26/2016
GNRT
NON-FINAL ACTION E-MAILED
07/26/2016
CNRT
NON-FINAL ACTION WRITTEN
07/26/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/25/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2016
GNRT
NON-FINAL ACTION E-MAILED
04/08/2016
CNRT
NON-FINAL ACTION WRITTEN
04/08/2016
DOCK
ASSIGNED TO EXAMINER
04/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/30/2015
NWAP
NEW APPLICATION ENTERED
12/28/2015
Continuous trademark protection
Get notified about every new filing that threatens PHARMATHEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.